AKT1 and neoplasm: Several studies have shown that FGF-2 is a key tumour-promoting factor, and it promotes tumour progression through downstream pro-survival signalling pathways such as, RAS-MAPK, PI3K-AKT, PLCγ, and signal transducer and activator of transcription (STAT)10.